Sex-specific serum biomarker patterns in adults with Asperger's syndrome

Molecular Psychiatry

Volumn 16, Issue 12, 2011, Pages 1213-1220

  Schwarz, E ^a   Guest, P C ^a   Rahmoune, H ^a   Wang, L ^a   Levin, Y ^a   Ingudomnukul, E ^b   Ruta, L ^b,c   Kent, L ^b,d   Spain, M ^e   Baron Cohen, S ^b   Bahn, S ^a,f  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CATANIA   (Italy)

^d UNIVERSITY OF ST ANDREWS   (United Kingdom)

^e Rules Based Medicine   (United States)

^f ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Asperger's syndrome; biomarker; gender; profiling; serum; sexual dimorphism

Indexed keywords

ANDROGEN; APOLIPOPROTEIN C3; ASPARTATE AMINOTRANSFERASE; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 7; BRAIN DERIVED NEUROTROPHIC FACTOR; CHROMOGRANIN A; CONNECTIVE TISSUE GROWTH FACTOR; EPITHELIAL DERIVED NEUTROPHIL ACTIVATING FACTOR 78; ERYTHROPOIETIN; FATTY ACID BINDING PROTEIN; GRANULOCYTE COLONY STIMULATING FACTOR; GROWTH HORMONE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 3; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 7; LUTEINIZING HORMONE; SORTILIN; STEM CELL FACTOR; TENASCIN; TESTOSTERONE; THROMBOPLASTIN; THROMBOPOIETIN; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; ASPERGER SYNDROME; BLOOD SAMPLING; CELL ADHESION; CLINICAL ARTICLE; CYTOKINE RELEASE; FEMALE; HORMONE RELEASE; HUMAN; IMMUNOASSAY; MALE; MOLECULAR PATHOLOGY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEX DIFFERENCE;

ADULT; ASPERGER SYNDROME; BIOLOGICAL MARKERS; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROTEOMICS; PSYCHOLOGICAL TESTS; SENSITIVITY AND SPECIFICITY; SEX CHARACTERISTICS; TESTOSTERONE;

EID: 80055082702     PISSN: 13594184     EISSN: 14765578     Source Type: Journal    
DOI: 10.1038/mp.2010.102     Document Type: Article

References (43)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental disorders. 4th Edition Text Revision: DSM-IVTR (2000). ISBN: 0890420256.
2. Volkmar FR, State M, Klin A. Autism and autism spectrum disorders: diagnostic issues for the coming decade. J Child Psychol Psychiatry 2009; 50: 108-115.
3. Baron-Cohen S, Scott FJ, Allison C, Williams J, Bolton P, Matthews FE et al. Prevalence of autism-spectrum conditions: UK school-based population study. Br J Psychiatry 2009; 194: 500-509.
4. Wing L. Asperger's syndrome: a clinical account. Psychol Med 1981; 11: 115-129. (Pubitemid 11148565)
5. Baron-Cohen S. The extreme male brain theory of autism. Trends Cogn Sci 2002; 6: 248-254. (Pubitemid 34597232)
6. Knickmeyer RC, Wheelwright S, Baron-Cohen SB. Sex-typical play: masculinization/defeminization in girls with an autism spectrum condition. J Autism Dev Disord 2008; 38: 1028-1035.
7. Baron-Cohen S, Knickmeyer RC, Belmonte MK. Sex differences in the brain: implications for explaining autism. Science 2005; 310: 819-823. (Pubitemid 41567334)
8. Auyeung B, Baron-Cohen S, Ashwin E, Knickmeyer R, Taylor K, Hackett G. Fetal testosterone and autistic traits. Br J Psychol 2009; 100(Pt 1): 1-22.
9. Auyeung B, Baron-Cohen S, Chapman E, Knickmeyer R, Taylor K, Hackett G. Foetal testosterone and the child systemizing quotient. Eur J Endocrinol 2006; 155(suppl 1): S123.
10. Chapman E, Baron-Cohen S, Auyeung B, Knickmeyer R, Taylor K, Hackett G. Fetal testosterone and empathy: evidence from the empathy quotient (EQ) and the 'reading the mind in the eyes' test. Soc Neurosci 2006; 1: 135-148.
11. Ingudomnukul E, Baron-Cohen S, Wheelwright S, Knickmeyer R. Elevated rates of testosterone-related disorders in women with autism spectrum conditions. Horm Behav 2007; 51: 597-604. (Pubitemid 46770756)
12. Manning JT, Baron-Cohen S, Wheelwright S, Sanders G. The 2nd to 4th digit ratio and autism. Dev Med Child Neurol 2001; 43: 160-164. (Pubitemid 32233075)
13. Henningsson S, Jonsson L, Ljunggren E, Westberg L, Gillberg C, Rastam M et al. Possible association between the androgen receptor gene and autism spectrum disorder. Psychoneuroendocrinology 2009; 34: 752-761.
14. Sugie Y, Sugie H, Fukuda T, Osawa J. Study of HOXD genes in autism particularly regarding the ratio of second to fourth digit length. Brain Dev 2009; 32: 356-361.
15. Chakrabarti B, Dudbridge F, Kent L, Wheelwright S, Hill-Cawthorne G, Allison C et al. Genes related to sex steroids, neural growth, and social-emotional behavior are associated with autistic traits, empathy, and Asperger syndrome. Autism Res 2009; 2: 157-177.
16. Courchesne E, Carper R, Akshoomoff N. Evidence of brain overgrowth in the first year of life in autism. JAMA 2003; 290: 337-344. (Pubitemid 37430519)
17. Castellani ML, Conti CM, Kempuraj DJ, Salini V, Vecchiet J, Tete S et al. Autism and immunity: revisited study. Int J Immunopathol Pharmacol 2009; 22: 15-19.
18. Vojdani A, Mumper E, Granpeesheh D, Mielke L, Traver D, Bock K et al. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J Neuroimmunol 2008; 205: 148-154.
19. Enstrom AM, Van de Water JA, Ashwood P. Autoimmunity in autism. Curr Opin Investig Drugs 2009; 10: 463-473.
20. Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LMet al. Towards complete and accurate reporting of studies of diagnostic accuracy: the STARD initiative. Standards for Reporting of Diagnostic Accuracy. Clin Chem 2003; 49: 1-6. (Pubitemid 36078546)
21. Baron-Cohen S, Wheelwright S, Skinner R, Martin J, Clubley E. The autism-spectrum quotient (AQ): evidence from Asperger syndrome/high-functioning autism, males and females, scientists and mathematicians. J Autism Dev Disord 2001; 31: 5-17.
22. Wheelwright S, Baron-Cohen S, Goldenfeld N, Delaney J, Fine D, Smith R et al. Predicting Autism Spectrum Quotient (AQ) from the Systemizing Quotient-Revised (SQ-R) and Empathy Quotient (EQ). Brain Res 2006; 1079: 47-56.
23. Wakabayashi A, Baron-Cohen S, Wheelwright S, Tojo Y. The Autism-Spectrum Quotient (AQ) in Japan: a cross-cultural comparison. J Autism Dev Disord 2006; 36: 263-270. (Pubitemid 43885384)
24. Hoekstra RA, Bartels M, Cath DC, Boomsma DI. Factor structure, reliability and criterion validity of the Autism-Spectrum Quotient (AQ): a study in Dutch population and patient groups. J Autism Dev Disord 2008; 38: 1555-1566.
25. Woodbury-Smith MR, Robinson J, Wheelwright S, Baron-Cohen S. Screening adults for Asperger Syndrome using the AQ: a preliminary study of its diagnostic validity in clinical practice. J Autism Dev Disord 2005; 35: 331-335. (Pubitemid 41125971)
26. Bishop DV, Maybery M, Maley A, Wong D, Hill W, Hallmayer J. Using self-report to identify the broad phenotype in parents of children with autistic spectrum disorders: a study using the Autism-Spectrum Quotient. J Child Psychol Psychiatry 2004; 45: 1431-1436. (Pubitemid 39445610)
27. Bertenshaw GP, Yip P, Seshaiah P, Zhao J, Chen TH, Wiggins WS et al. Multianalyte profiling of serum antigens and autoimmune and infectious disease molecules to identify biomarkers dysregulated in epithelial ovarian cancer. Cancer Epidemiol Biomarkers Prev 2008; 17: 2872-2881.
28. Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology 1990; 1: 43-46. (Pubitemid 20255621)
29. Hastie T, Tibshirani R, Friedman JH. The Elements of Statistical Learning. Springer-Verlag: New York, 2003.
30. Hana V, Silha JV, Justova V, Lacinova Z, Stepan JJ, Murphy LJ. The effects of GH replacement in adult GH-deficient patients: changes in body composition without concomitant changes in the adipokines and insulin resistance. Clin Endocrinol (Oxf) 2004; 60: 442-450. (Pubitemid 38482506)
31. Guest P, L Wang L, Harris L, Burling K, Levin Y, Ernst A et al. Increased levels of circulating insulin-related peptides in first onset, antipsychotic na?̈ve schizophrenia patients. Mol Psychiatry 2010; 15: 118-119.
32. Kanda N, Tsuchida T, Tamaki K. Testosterone inhibits immunoglobulin production by human peripheral blood mononuclear cells. Clin Exp Immunol 1996; 106: 410-415. (Pubitemid 26359912)
33. Escobar ME, Ropelato MG, Ballerini MG, Gryngarten MG, Rudaz MC, Veldhuis JD et al. Acceleration of luteinizing hormone pulse frequency in adolescent girls with a history of central precocious puberty with versus without hyperandrogenism. Horm Res 2007; 68: 278-285. (Pubitemid 350059700)
34. Barontini M, Garcia-Rudaz MC, Veldhuis JD. Mechanisms of hypothalamic-pituitary-gonadal disruption in polycystic ovarian syndrome. Arch Med Res 2001; 32: 544-552. (Pubitemid 34031746)
35. Ragusa L, Elia M, Scifo R. Growth hormone deficit in autism. J Autism Dev Disord 1993; 23: 421-422.
36. Mills JL, Hediger ML, Molloy CA, Chrousos GP, Manning-Courtney P, Yu KF et al. Elevated levels of growth-related hormones in autism and autism spectrum disorder. Clin Endocrinol (Oxf) 2007; 67: 230-237. (Pubitemid 47076299)
37. Vanhala R, Turpeinen U, Riikonen R. Low levels of insulin-like growth factor-I in cerebrospinal fluid in children with autism. Dev Med Child Neurol 2001; 43: 614-616. (Pubitemid 32842534)
38. Kebapcilar L, Taner CE, Kebapcilar AG, Alacacioglu A, Sari I. Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome. Arch Gynecol Obstet; 28 March 2009 [e-pub ahead of print].
39. Golden SH, Ding J, Szklo M, Schmidt MI, Duncan BB, Dobs A. Glucose and insulin components of the metabolic syndrome are associated with hyperandrogenism in postmenopausal women: the atherosclerosis risk in communities study. Am J Epidemiol 2004; 160: 540-548. (Pubitemid 39215630)
40. Zheng Z, Li M, Lin Y, Ma Y. Effect of rosiglitazone on insulin resistance and hyperandrogenism in polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi 2002; 37: 271-273.
41. van Gent T, Heijnen CJ, Treffers PD. Autism and the immune system. J Child Psychol Psychiatry 1997; 38: 337-349. (Pubitemid 27373343)
42. Molloy CA, Morrow AL, Meinzen-Derr J, Schleifer K, Dienger K, Manning-Courtney P et al. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 2006; 172: 198-205. (Pubitemid 43277506)
43. Le-Niculescu H, Kurian SM, Yehyawi N, Dike C, Patel SD, Edenberg HJ et al. Identifying blood biomarkers for mood disorders using convergent functional genomics. Mol Psychiatry 2009; 14: 156-174.